Immune-mediated tumor evolution: Nanog links the emergence of a stem like cancer cell state and immune evasion
Authors:
Open Access
- 3 July 2014
- journal article
- Published by Taylor & Francis in OncoImmunology
- Vol. 3 (7) , e947871
Abstract
Tumor cells undergo molecular evolution under immune pressure. Using a murine metastatic lung cancer model, we recently reported that evolutionary pressure enforced through vaccination incites gain of Nanog, a master transcription factor that mediates both emergence of a stem-like cancer cell state and immune evasion. Thus, therapeutic strategies aiming to blunt NANOG's expression in patient tumors may improve the clinical management of cancer.Keywords
This publication has 8 references indexed in Scilit:
- Nanog signaling in cancer promotes stem-like phenotype and immune evasionJournal of Clinical Investigation, 2012
- Cancer Vaccination Drives Nanog-Dependent Evolution of Tumor Cells toward an Immune-Resistant and Stem-like PhenotypeCancer Research, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Ectopic Expression of Vascular Cell Adhesion Molecule-1 as a New Mechanism for Tumor Immune EvasionCancer Research, 2007
- Survival signalling by Akt and eIF4E in oncogenesis and cancer therapyNature, 2004
- Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem CellsCell, 2003
- Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription FactorCell, 1999
- Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death MachineryCell, 1997